Improved Assessment of Minimal Residual Disease in B Cell Malignancies Using Fluorogenic Consensus Probes for Real-Time Quantitative PCR
Leukemia - United Kingdom
doi 10.1038/sj.leu.2401831
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2000
Authors
Publisher
Springer Science and Business Media LLC